Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Skin equivalent culture

a technology of skin and composition, applied in the field of skin equivalent culture, can solve the problems of concave rather than concentric shape, loss of height of the construct, and doubt that the collagen will obtain its final structur

Inactive Publication Date: 2016-11-17
SMITH & NEPHEW INC
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a way to create a strong and rigid connective tissue equivalent by freeze-drying a construct and then seeding it with epidermal keratinocytes. This helps to further strengthen the collagen matrix and make it act as a dermal replacement in a "living skin equivalent." Other ingredients are added to the growth media to promote post-translational modifications to the collagen, and physical stress can be applied to enhance the properties of the construct. The freeze-drying process also adds stability and strength to the ensemble of ingredients.

Problems solved by technology

This results in a concave rather than the desired convex shape, and loss in height of the construct.
Whilst it is accepted that collagen will be produced in the period of incubation (10 days) as described by Hewitt et al., without the addition of substantial means of synthesizing or obtaining ascorbic acid (vitamin C) it is doubtful that the collagen will obtain its final structure that is crucial to its function in skin, tendon, etc.
Furthermore, within the 10 day incubation described in Hewitt et al., it is unlikely that sufficient structure will form in and between collagen fibers for the resulting construct to be useful as a “living skin equivalent”.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Skin equivalent culture
  • Skin equivalent culture
  • Skin equivalent culture

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Discussion of Prior Art and the Present Invention

[0048]D1—Hansbrough J F, Morgan J L, Greenleaf G E and Bartel R. (1993). Composite grafts of Human keratinocytes grown on a polyglactin mesh-cultured fibroblast dermal substitute function as a bilayer skin replacement in full-thickness wounds on athymic mice. J. Burn Care and Rehab. 14 (5), 485-494.[0049]D2—Geesin et al, Regulation of Collagen Synthesis in human dermal fibroblasts in contracted collagen gels by ascorbic acid, growth factors, and inhibitors of lipid peroxidation. Experimental Cell Research 206, 283-290.[0050]D3—WO 03 / 41568 (University of New Jersey, Hewitt et. al) A Three dimensional matrix for producing living tissue equivalents.

Overview of ICX-SKN—Skin Equivalent Culture, According to the Invention:

[0051]ICX-SKN has been designed as an active cell therapy consisting of human dermal fibroblasts (HDFs) embedded in fibrin gels which are allowed to mature over several weeks. A key aspect of this maturation period is that...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a method of preparing a collagenous construct comprising (i) casting viable collagen-producing human dermal fibroblasts in a support matrix comprising fibrin onto a support material, (ii) incubating in situ said support matrix with said viable collagen-producing human dermal fibroblasts in a collagen-inducing medium thereby (a) inducing or enhancing collagen production by said viable collagen-producing human dermal fibroblasts to form a collagenous construct, and (b) degrading said fibrin, (iii) rendering said collagenous construct free of said viable collagen-producing human dermal fibroblasts, and (iv) cross-linking said collagenous construct with a chemical or exposure to ultraviolet light.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 12 / 902,710 filed Oct. 12, 2010, which is a continuation of U.S. application Ser. No. 11 / 886,113, now U.S. Pat. No. 8,114,670, filed Jun. 24, 2008, which is a national phase application under 35 U.S.C. §371 of International Application No. PCT / GB2006 / 000890, filed Mar. 14, 2006, which claims the benefit of Great Britain Application No. 0505202.2, filed Mar. 14, 2005. The contents of all of these referenced applications are incorporated into the present application by reference.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to methods of forming soft connective tissue compositions such as skin equivalents, compositions made by the methods and their uses.[0004]2. Description of Related Art[0005]Bioengineered skin substitutes have emerged over the past two decades, with the initial intention to replace autograft, allograft, and xenog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/071A61L27/36A61L27/24A61L27/60A61L27/20A61L27/22A61L27/38A61L27/54
CPCC12N5/0698C12N2500/30A61L27/3691A61L27/3687A61L27/54A61L27/60A61L27/20A61L27/225A61L27/24C12N2533/56C12N2501/11C12N2500/25C12N2501/15C12N2500/32A61L27/3839A61L27/3804A61L27/3886A61L27/3895C12N2502/094C12N2502/1323A61P17/02
Inventor KEMP, PAULSHERING, DAVIDSHERING, ANDREWJOHNSON, PENNYMARSHALL, DAMIAN
Owner SMITH & NEPHEW INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products